[HTML][HTML] Photodynamic therapy (PDT) for malignant brain tumors–where do we stand?

…, AW Girotti, S Jogal, PS LaViolette, JM Connelly… - Photodiagnosis and …, 2015 - Elsevier
Introduction What is the current status of photodynamic therapy (PDT) with regard to treating
malignant brain tumors? Despite several decades of effort, PDT has yet to achieve standard …

Environmental risk factors for brain tumors

JM Connelly, MG Malkin - Current neurology and neuroscience reports, 2007 - Springer
JM: Occupational exposure to magnetic fields relative to mortality from brain tumours:
updated and revised findings from a study of United kingdom electricity generation and …

[PDF][PDF] Glioma progression is shaped by genetic evolution and microenvironment interactions

…, A Brodbelt, KR Bulsara, AV Castro, JM Connelly… - Cell, 2022 - cell.com
The factors driving therapy resistance in diffuse glioma remain poorly understood. To
identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA …

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

…, MG Malkin, SD Rand, JM Connelly… - Journal of Magnetic …, 2010 - Wiley Online Library
Purpose: To present comprehensive examinations of the assumptions made in functional
diffusion map (fDM) analyses and provide a biological basis for fDM classification. Materials …

Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women

…, JR Kanter, LC Hemphill, JM Connelly… - The Journal of …, 2006 - academic.oup.com
Context: Increased common carotid intima-media thickness (IMT) is predictive of coronary
artery disease and stroke. Objective: In this study, we investigated common carotid IMT by …

[HTML][HTML] High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: case series and review of the literature

…, ZA Jawa, CC Huang, JM Connelly… - … /Oncology and Stem Cell …, 2019 - Elsevier
Leptomeningeal metastasis (LM) in breast cancer is associated with significant morbidity
and mortality. While there is currently no standard therapy, treatment options include …

[HTML][HTML] Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency

…, MM Al-Gizawiy, WM Mueller, SD Rand, JM Connelly… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Glioblastoma remains the most common, malignant primary cancer of the central nervous
system with a low life expectancy and an overall survival of less than 1.5 years. The treatment …

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

…, SD Rand, PS LaViolette, JM Connelly… - Journal of neuro …, 2011 - Springer
Anti-angiogenic agents targeting brain tumor neovasculature may increase progression-free
survival in patients with recurrent malignant gliomas. However, when these patients do …

Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome

…, JR Kanter, LC Hemphill, JM Connelly… - The Journal of …, 2006 - academic.oup.com
Context: Little is known regarding carotid intimal medial thickness (IMT) in HIV-infected
women and the risk factors for subclinical atherosclerosis in this population, including …

Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics

…, EJ Cochran, RG Hoffmann, JM Connelly… - Journal of neuro …, 2018 - Springer
The goal of this study is to spatially discriminate tumor from treatment effect (TE), within the
contrast-enhancing lesion, for brain tumor patients at all stages of treatment. To this end, the …